Cannabis Science Inc (fka CBIS)

[qwertytrader]

CBIS Cancer Treatment Review - Killing Cancer

Cannabis Science Reports Cancer Tumors Continues to Shrink & Die as Apparent Pieces of the Dying Cancer Tumors Begin to Fall ...

March 8, 2012

Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products is monitoring the outstanding progress of the 3rd Self-Medicated Cannabis Patient with Clear Continued Improvement. This self-medicating patient has what his doctors describe as the worst case of squamous cell carcinoma the had ever seen. This patient’s tumors, while resistant to conventional treatment, continues to make obvious improvement with the use of cannabis extracts

http://ih.advfn.com/p.php?pid=nmona&article=51543613

http://www.cannabisscience.com/download/patientthree_mar72012_update5.pdf

OFFICIAL PHOTO RELEASE FROM CBIS

------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Presents Newest Case Photos of the 3rd Critical Squamous Cell Carcinoma Self-Medicated Cannabis Patient
February 23, 2012

Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products is monitoring the outstanding progress of the 3rd Self-Medicated Cannabis Patient with Clear Continued Improvement. This self-medicating patient has what his doctors describe as the worst case of squamous cell carcinoma the had ever seen. This patient’s tumors, while resistant to conventional treatment, continues to make obvious improvement with the use of cannabis extracts

http://ih.advfn.com/p.php?pid=nmona&article=51327206

http://www.cannabisscience.com/download/patientthree_feb222012_update4.pdf

OFFICIAL PHOTO RELEASE FROM CBIS


------------------------------------------------------------------
------------------------------------------------------------------


Cannabis Science Awaits Full Biopsy Report As Newest Series of Photos Shows Cancer Lesion Evidently Completely Killed & Hair
February 7, 2012

Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to present the newest set of photographs showing evidence that the cancer cells appear to have been killed over the course of treatment from the 2nd self-administering cancer patient suffering from squamous cell carcinoma on her arm

http://ih.advfn.com/p.php?pid=nmona&article=51064492

http://www.cannabisscience.com/download/2ndpatient_casestudy_feb072012_update.pdf

OFFICIAL PHOTO RELEASE FROM CBIS


------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Reports Success For 4th Brand New Self-Administering Cancer Patient
February 2, 2012

Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to introduce a 4th cancer patient with basal cell carcinoma (skin cancer) on his left nostril, who is self-administering a topical cannabis extract and having noticeable results.

http://ih.advfn.com/p.php?pid=nmona&article=51011740

http://www.cannabisscience.com/download/patientfour_feb012012.pdf

OFFICIAL PHOTO RELEASE FROM CBIS


------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying & Areas That Are Now Pain
January 30, 2012

Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to share new photographs from this cancer patient with severe squamous cell carcinoma. These pictures clearly show that this patient, with previously treatment-resistant tumors, continues to make obvious improvement. The tumors appear to be dying and then healing after treatment with cannabis-based extracts

http://ih.advfn.com/p.php?pid=nmona&article=50950966

http://www.cannabisscience.com/download/patientthree_jan302012_update2.pdf

OFFICIAL PHOTO RELEASE FROM CBIS






------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Updates Latest Remarkable Follow up Photographs Received from 3rd Cancer Patient
January 24, 2012

Today Cannabis Science receives the latest photographs for the 3rd self-administering cancer patient, mentioned in the previous news release dated, January 11, 2012. The treatment process is ongoing, but the results have been visually dramatic, the cannabis extracts have drastically shrunk some tumors and others are gone.

http://ih.advfn.com/p.php?pid=nmona&article=50870675

http://www.cannabisscience.com/download/patientthree_jan232012_update1.pdf

OFFICIAL PHOTO RELEASE FROM CBIS




------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Updates Second Medical Cannabis Cancer Patient Suffering from Squamous Cell Carcinoma Photo-documents
January 19, 2012

PROCEDURE AND RESULTS
The series of photos below documents the disappearance of a biopsied squamous cell tumor after self-administration of topical cannabis extracts over a 3 month period. After treatment with cannabis extract, the tumor was expelled from below the surface, killed, and healed.

http://ih.advfn.com/p.php?pid=nmona&article=50813674

http://www.cannabisscience.com/download/2ndpatient_casestudy.pdf

OFFICIAL PHOTO RELEASE FROM CBIS


------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Reports Apparent Success for 3rd Self-Medicated Cancer Patient
January 11, 2012

The first picture shows a large tumor protruding a few inches above the surface of the patient's skull prior to treatment. The cannabis-based extract was applied into the holes and the surrounding tissue that are seen in this patient’s scalp that extended down to the skull. The second photograph shows the patient's head after receiving one of many radiation treatments. Subsequent photos demonstrate what appears to be the cannabis extract drawing out, and killing the cancer cells from these lesions.

While this patient's self-administered treatment with cannabis extracts is still in progress, the results after just two weeks of treatment are dramatic. Some of the tumors have disappeared and others have significantly shrunk to a fraction of their original size. Simultaneously, the patient has had a significant decrease in pain, improved sleeping (the 1st full night of sleep in 3 years), as well as relief from the symptoms of multiple sclerosis that the patient also suffers from. This self-treatment is a work in progress.

Cannabis Science is showing the general public unbiased evidence as we acquire it independent of the final outcome. As the treatment continues, and physician determinations are made, we will continue to update you so that you can follow the effectiveness of this treatment as it progresses.

http://www.cannabisscience.com/news-a-media/press-releases/257-cbis-reports-apparent-success-for-3rd.html

OFFICIAL PHOTO RELEASE FROM CBIS




------------------------------------------------------------------
------------------------------------------------------------------

More Cannabis Science Brand Extracts Successful Cancer Treatments Confirmed As Self Medicating Squamous Cell Carcinoma Patient Reports Continued Shrinking of Cancer Tumor
January 3, 2012

http://www.cannabisscience.com/news-a-media/press-releases/253-more-cbis-brand-extracts-successful.html

------------------------------------------------------------------
------------------------------------------------------------------

Second Self Medicated Medical Cannabis Cancer Patient Reports Cannabis Science Brand Extracts Killing Cancer Cells
December 12, 2011

http://www.cannabisscience.com/news-a-media/press-releases/247-second-self-medicated-medical-cannabis.html

------------------------------------------------------------------
------------------------------------------------------------------

Cannabis Science Provides Physician’s Documentation That Confirms Successful Treatment of Skin Cancer
April 6, 2011

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS), US biotech company developing pharmaceutical cannabis products. On March 9, 2011 Cannabis Science announced that we would follow up our press release with medical documentation regarding the effectiveness of our cannabis extracts for treating skin cancer as was documented photographically in our earlier press release of February 22, 2011. We are pleased to announce that we have physician’s documentation that confirms the successful treatment of basal cell carcinoma that resulted from the application of a topical cannabis extract.

Please visit www.cannabisscience.com to view the “Breaking News” of the successful results and images of the self-administered cancer treatments along with the physician's documentation after 4pm EST., today.

Currently, there is a tremendous amount of controversy with respect to the effects that cannabinoids have on cancers. Endocannabinoids, phytocannabinoids, and synthetic cannabinoids have demonstrated cancer killing and anti-metastatic properties in tissue culture and in animal models. While formal, proper, FDA approved clinical trials that would prove or disprove the therapeutic potential of cannabis extracts for treating cancers; trials have not been carried out. Nevertheless, a significant number of anecdotal observations have accumulated that suggest people suffering from a variety of cancers appear to have been cured by ingesting what is known as “Rick Simpson's hemp oil”.
There is widespread ignorance regarding the endocannabinoid system by medical professionals and laymen alike. The first hint that an endocannabinoid system existed resulted from an experiment published in 1988. Because of the endemic political and social bias against medical cannabis, nurtured by decades of misinformation, Cannabis Science has chosen a path that we feel will have the greatest probability of successfully traversing the FDA approval process. Our initial test product will only be topical, and will be formulated to reduce any internal consumption and thus reduce any abuse potential. With these considerations in mind, we will initially seek FDA approval for topically applied cannabis extracts for the treatment of basal cell carcinoma, a common form of skin cancer.

According to the National Cancer Institute ( www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001827/), basal cell carcinoma is the most frequently occurring cancer in the United States. Because of the horrific impact that cancer in general has on so many people worldwide, Cannabis Science has decided to make basal cell carcinoma its first target for clinical trial.

OFFICIAL PHOTO RELEASE FROM CBIS


------------------------------------------------------------------
------------------------------------------------------------------



$CBIS

Find CBIS News at

www.cannabisscience.com

Cannabis Science Inc.
Trading Symbol: CBIS